HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

David G Kirsch Selected Research

Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)

1/2022Targeting the ATM Kinase to Enhance the Efficacy of Radiotherapy and Outcomes for Cancer Patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


David G Kirsch Research Topics

Disease

119Neoplasms (Cancer)
04/2024 - 01/2004
79Sarcoma (Soft Tissue Sarcoma)
04/2024 - 04/2007
16Neoplasm Metastasis (Metastasis)
10/2023 - 01/2013
9Lung Neoplasms (Lung Cancer)
01/2022 - 07/2005
9Carcinogenesis
10/2021 - 01/2012
8Ataxia Telangiectasia (Louis Bar Syndrome)
12/2023 - 08/2014
7Brain Neoplasms (Brain Tumor)
01/2021 - 01/2004
6Hypoxia (Hypoxemia)
11/2023 - 10/2013
6Breast Neoplasms (Breast Cancer)
01/2021 - 03/2005
5Glioma (Gliomas)
10/2023 - 01/2013
5Acute Radiation Syndrome
12/2021 - 05/2014
4Uveal melanoma
12/2022 - 05/2014
4COVID-19
12/2020 - 01/2020
4Neurofibrosarcoma (MPNST)
01/2020 - 10/2012
3Wounds and Injuries (Trauma)
12/2023 - 07/2013
3Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 03/2010
3Myxoid Liposarcoma
10/2021 - 01/2019
3Adenocarcinoma of Lung
01/2021 - 10/2005
3Melanoma (Melanoma, Malignant)
06/2020 - 01/2018
3Margins of Excision
01/2019 - 07/2010
3Radiation Injuries (Radiation Sickness)
01/2019 - 03/2013
3Residual Neoplasm
01/2016 - 10/2015
2Inflammation (Inflammations)
12/2023 - 12/2023
2Leukemia
11/2023 - 11/2013
2Pathologic Complete Response
01/2023 - 10/2012
2Genetic Translocation (Chromosomal Translocation)
10/2021 - 11/2013
2Lymphoma (Lymphomas)
01/2021 - 09/2015
2Diffuse Intrinsic Pontine Glioma
01/2021 - 01/2013
2Rhabdomyosarcoma
12/2013 - 01/2012
1Squamous Cell Carcinoma of Head and Neck
12/2023
1Second Primary Neoplasms (Neoplasms, Second)
12/2023
1Cognitive Dysfunction
12/2023
1Neuroinflammatory Diseases
12/2023
1Medulloblastoma
12/2023
1Chromosomal Instability (Chromosome Stability)
11/2023

Drug/Important Bio-Agent (IBA)

11Recombinases (Recombinase)IBA
09/2022 - 05/2012
10Cre recombinaseIBA
02/2024 - 08/2007
9Phosphotransferases (Kinase)IBA
10/2023 - 01/2012
9MicroRNAs (MicroRNA)IBA
01/2022 - 12/2009
8Proteins (Proteins, Gene)FDA Link
02/2024 - 05/2014
7Peptide Hydrolases (Proteases)FDA Link
08/2016 - 10/2005
7Contrast MediaIBA
10/2015 - 01/2012
6RNA (Ribonucleic Acid)IBA
12/2023 - 12/2013
6DNA (Deoxyribonucleic Acid)IBA
08/2023 - 03/2015
6Small Interfering RNA (siRNA)IBA
10/2022 - 05/2013
6IodineIBA
01/2018 - 01/2012
5Oncogene Proteins (Oncogene Protein)IBA
02/2024 - 01/2019
5Biomarkers (Surrogate Marker)IBA
04/2023 - 07/2005
5Iodine-125IBA
12/2022 - 05/2014
5Doxorubicin (Adriamycin)FDA LinkGeneric
01/2020 - 01/2012
5Protons (Proton)IBA
01/2018 - 05/2004
5Fluorescent Dyes (Fluorescent Probes)IBA
01/2016 - 11/2012
4Immune Checkpoint InhibitorsIBA
04/2024 - 10/2018
4GoldIBA
01/2018 - 03/2013
4CathepsinsIBA
05/2013 - 10/2005
3EpitopesIBA
02/2024 - 09/2023
3IonsIBA
06/2023 - 07/2016
3dipinacoline glutamateIBA
01/2022 - 01/2013
3Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2018 - 05/2013
3EnzymesIBA
01/2016 - 10/2013
3Trastuzumab (Herceptin)FDA Link
04/2008 - 03/2005
2MethylcholanthreneIBA
01/2024 - 11/2019
2CarcinogensIBA
01/2024 - 11/2019
2Transcription Factors (Transcription Factor)IBA
11/2023 - 01/2022
2Glucose (Dextrose)FDA LinkGeneric
07/2022 - 01/2021
2Glycogen Synthase (Synthase I)IBA
01/2020 - 05/2014
2CarbonIBA
01/2019 - 01/2018
2CateninsIBA
01/2016 - 09/2014
2Acridine OrangeIBA
01/2016 - 01/2013
2AcriflavineIBA
11/2015 - 01/2013
2dactolisibIBA
03/2015 - 01/2012
2GadoliniumIBA
06/2013 - 07/2010
1Radioisotopes (Radionuclides)IBA
04/2024
1GuanineIBA
01/2024
1Phosphates (Orthophosphate)IBA
01/2024
1Toll-Like Receptor 9IBA
01/2024
1Granzymes (Granzyme)IBA
01/2024
1CytosineIBA
01/2024
1InterferonsIBA
01/2024
1OligodeoxyribonucleotidesIBA
01/2024
1Radiation-Sensitizing AgentsIBA
12/2023
1Checkpoint Kinase 1IBA
12/2023
1BAY 1895344IBA
12/2023
1Leptin ReceptorsIBA
11/2023
1Telomerase (Telomerase Reverse Transcriptase)IBA
11/2023

Therapy/Procedure

84Radiotherapy
04/2024 - 01/2004
42Therapeutics
04/2024 - 02/2007
8Immunotherapy
04/2024 - 01/2018
8Neoadjuvant Therapy
01/2023 - 11/2011
6Drug Therapy (Chemotherapy)
01/2020 - 11/2004
5Brachytherapy
03/2022 - 07/2016
4Proton Therapy
01/2022 - 01/2004
3Surgical Amputation (Amputations)
01/2023 - 10/2014
3Aftercare (After-Treatment)
02/2019 - 07/2009
2Injections
01/2023 - 01/2017
2Chemoradiotherapy
10/2019 - 01/2016
2Adjuvant Radiotherapy
10/2016 - 07/2013
2Image-Guided Radiotherapy
07/2016 - 07/2015
2Transplantation
08/2015 - 01/2015
1Combined Modality Therapy
12/2023